6Rosa GR,Takizawa N,Schimidt D,et al.Surgical treatment of superior vena cava syndrome caused by invasive thymoma[J] .Rev Bras Cir Cardiovasc,2010,25 (2):257-260.
4Engels EA, Pfeiffer RiM. Malignant thymoma in the United States: demographic patterns in incidence and associations with subsequent malignancies. Int J Cancer, 2003, 105(4) : 546-551.
5Wright CD, Wain JC, Wong DR, et al. Predictors of recurrence in thymic tumors: importance of invasion. WHO histology and size. J Thorac Cardiovasc Surg, 2005, 130(5): 1413-1421.
6Girard N, Mornex F, Van Houtte P, et al. Thymoma: a focus on current therapeutic management. J Thorac Oncol, 2009, 4( 1 ): 119-126.
7Casey EM, Kiel PJ, Loehrer PJ. Clinical management of thymoma patients. Hematol Oncol Clin North Am, 2008, 22(3): 457-473.
8Sadohara J, Fujimoto K, Muller NL, et al. Thymic epithelial tumors: comparison of CT and MR imaging findings of low-risk thymomas, high-risk thymomas, and thymic carcinomas. EurJ Radiol, 2006, 60 (1): 70-79.
9Endo M, Nakagawa K, Ohde Y, et al. Utility of ^18FDG-PET for differentiating the grade of malignancy in thymic epithelial tumors. Lung Cancer, 2008, 61(3): 350-355.
10Sung YM, Lee KS, Kim BT, et al. ^18F-FDG PET/CT of thymic epithelial tumors: usefulness for distinguishing and staging tumor subgroups. J Nucl Med, 2006, 47(10): 1628-1634.
